| Basics |
STAAR Surgical Company
Staar Surgical along with its subsidiaries designs, develops, manufactures and sells implantable lenses and delivery systems for the eye. The Company develops, produces, and markets intraocular lenses.
|
| IPO Date: |
March 2, 1992 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$1.25B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.56 | 2.45%
|
| Avg Daily Range (30 D): |
$0.61 | 2.29%
|
| Avg Daily Range (90 D): |
$0.42 | 1.60%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.28M |
| Avg Daily Volume (30 D): |
.71M |
| Avg Daily Volume (90 D): |
1.29M |
| Trade Size |
| Avg Trade Size (Sh.): |
79 |
| Avg Trade Size (Sh.) (30 D): |
70 |
| Avg Trade Size (Sh.) (90 D): |
102 |
| Institutional Trades |
| Total Inst.Trades: |
3,679 |
| Avg Inst. Trade: |
$2.74M |
| Avg Inst. Trade (30 D): |
$1.91M |
| Avg Inst. Trade (90 D): |
$2.24M |
| Avg Inst. Trade Volume: |
.06M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.38M |
| Avg Closing Trade (30 D): |
$2.42M |
| Avg Closing Trade (90 D): |
$3.02M |
| Avg Closing Volume: |
70.78K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-1.96
|
$.18
|
$-.34
|
|
Diluted EPS
|
$-1.95
|
$.18
|
$-.34
|
|
Revenue
|
$ 230.59M
|
$ 94.73M
|
$ 44.32M
|
|
Gross Profit
|
$ 170.33M
|
$ 77.88M
|
$ 32.8M
|
|
Net Income / Loss
|
$ -96.37M
|
$ 8.88M
|
$ -16.81M
|
|
Operating Income / Loss
|
$ -96.79M
|
$ 18.49M
|
$ -29.96M
|
|
Cost of Revenue
|
$ 60.26M
|
$ 16.86M
|
$ 11.52M
|
|
Net Cash Flow
|
$ 12.15M
|
$ 9.02M
|
$ -5.98M
|
|
PE Ratio
|
|
|
|
|
|
|
